BCL-6 negatively regulates macrophage proliferation by suppressing autocrine IL-6 production
Open Access
- 15 February 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 105 (4) , 1777-1784
- https://doi.org/10.1182/blood-2004-08-3171
Abstract
The transcription repressor BCL-6 is known to play critical roles in B-cell lymphomagenesis, germinal center formation, and balanced Th1/Th2 differentiation. In macrophages, although BCL-6 has also been shown to regulate the expression of several chemokine genes, its function in other aspects of macrophage biology has not been studied. In addition, the precise role of BCL-6 in cell proliferation is poorly understood in general. Here we report that BCL-6-/- macrophages hyperproliferate due to an accelerated G1/S transition accompanied by increased cyclin D2 and c-myc and decreased expression of p27. Crucial to this enhanced proliferation is spontaneous interleukin 6 (IL-6) production and signal transducer and activator of transcription 3 (STAT3) activation in BCL-6-/- macrophages. In colony-forming assays, BCL- 6-/- bone marrow progenitor cells form spontaneous macrophage colonies that can be inhibited by anti-IL-6 antibodies. Gene expression studies demonstrate that BCL-6 binds to several sequence motifs scattered in the IL-6 locus and can repress IL-6 transcription both in 293T cells and in macrophages. In conclusion, our results indicate that BCL-6 negatively regulates proliferation of the monocytic/macrophage lineage by suppressing an autocrine IL-6/STAT3-mediated gene expression program. Our work also suggests that BCL-6 prevents abnormal Th2 differentiation by suppressing basal level IL-6 production in antigen-presenting cells (APCs). (Blood. 2005;105:1777-1784)Keywords
This publication has 38 references indexed in Scilit:
- Transcriptional repressor BCL-6 immortalizes germinal center-like B cells in the absence of p53 functionOncogene, 2004
- Overexpression of a dominant negative form of STAT3 selectively impairs hematopoietic stem cell activityOncogene, 2002
- A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19ARF–p53 signalingGenes & Development, 2002
- Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1Nature, 2000
- RANTES and MIP-1α Activate Stats in T CellsPublished by Elsevier ,1998
- The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammationNature Genetics, 1997
- Interleukin (IL)-6 Directs the Differentiation of IL-4–producing CD4+ T CellsThe Journal of Experimental Medicine, 1997
- Murine Bone Marrow-Derived MacrophagesPublished by Springer Nature ,1989
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroyCell, 1982